Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review


Article ID: 6432
Vol 32, Issue 4S1, 2018
DOI: https://doi.org/10.54517/jbrha6432
Received: 8 September 2018; Accepted: 8 September 2018; Available online: 8 September 2018; Issue release: 8 September 2018

Abstract

The discovery that mesenchymal stem cells (MSCs) modulate inflammation and promote tissue regeneration has revolutionized stem cells-based therapy. However, some observations have raised questions about the limitations of their clinical use. On the other hand, recent findings have demonstrated that exosomes released by MSCs contribute significantly to their therapeutic effect and may be used as an alternative MSCs-based therapy in regenerative medicine. In this review, we summarize the current knowledge about the immunosuppressive capacity of MSCs-derived exosomes and we discuss the critical role of the surrounding microenvironment in the modulation of their regenerative and therapeutic potential.


Keywords

mesenchymal stem cells;exosomes;immunosuppression;inflammatory microenvironment;cell-free regenerative medicine


References

Supporting Agencies



Copyright (c) 2018




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).